Prognostic impact of metastatic lymph node ratio in advanced gastric cancer from cardiac and fundus

World Journal of Gastroenterology

Volumn 14, Issue 27, 2008, Pages 4383-4388

  Huang, Chang Ming ^a   Lin, Bi Juan ^a   Lu, Hui Shan ^a   Zhang, Xiang Fu ^a   Li, Ping ^a   Xie, Jian Wei ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Lymph node metastasis; Lymphadenectomy; Metastatic lymph node ratio; Prognosis; Stomach neoplasms

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CARDIA; CERVICAL LYMPH NODE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; STOMACH CANCER; STOMACH FUNDUS; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; STOMACH; STOMACH TUMOR;

ADULT; AGED; CARDIA; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; STOMACH; STOMACH NEOPLASMS;

EID: 55949125680     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4383     Document Type: Article

References (35)

1. Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, Murata K, Iwamoto K, Yashima R, Yamauchi H, Kikuchi S. Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004; 39: 380-384
2. Wu ZY, Li JH, Zhan WH, He YL, Wan J. Effect of lymph node micrometastases on prognosis of gastric carcinoma. World J Gastroenterol 2007; 13: 4122-4125
3. Higashi H, Natsugoe S. Ishigami S, Uenosona Y, Matsumoto M, Nakajo, A, Miyazono F, Hokita S, Takao S, Aikou T. Distribution of lymph node metastasis including micrometastasis in gastric cancer with submucosal invasion. World J Surg 2003; 27: 455-459
4. Saito H, Fukumoto Y, Osaki T, Yamada Y, Fukuda K, Tatebe S, Tsujitani S. Ikeguchi M. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 2008; 97: 132-135
5. Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric, carcinoma. J Surg Oncol 2007; 96: 95-101
6. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma-2nd English Edition. Gastric Cancer 1998; 1: 10-24
7. Sobin LH, Fleming ID. TNM, Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80: 1803-1804
8. Devesa SS, Fraumeni IF Jr. The rising incidence of gastric cardia cancer. J Natl Cancer Inst 1999; 91: 747-749
9. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002; 95: 2096-2102
10. Pinto-De-Sousa J, David L, Seixas M, Pimenta A. Clinopathologic profiles and prognosis of gastric carcinomas from the cardia, fundus/ body and antrum. Dig Sulg 2001; 18: 102-110
11. Griffiths EA, Pritchard SA, Mapstone NP, Welch IM. Emerging aspects of oesophageal and gastro-oesophageal junction cancer histopathology-an update for the surgical oncologist. World J Surg Oncol 2006; 4: 82
12. Dresner SM, Lamb PJ, Bennett MK, Hayes N, Griffin SM. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001; 129: 103-109
13. Kim DY, Seo KW, loo JK,, Park YK, Ryu SY, Kim HR, Kim YI, Kim SK. Prognostic factors inpatients with node-negative gastric carcinoma: a comparison with node-positive gastric carcinoma. Word J Gastroenterol 2006; 12: 1182-1186
14. de Manzoni G, Morgagni P, Roviello F, Di Leo A, Saragoni L, Marrelli D, Guglielmi A, Carli A, Folli S, Cordiano C. Nodal abdominal spread in adenocarcinoma of the cardia. Results of a multicenter prospective study. Gastric Cancer 1998; 146-151
15. Di Leo A, Marrelli D, Roviello F, Bernini M, Minicozzi A, Giacopuzzi S, Pedrazzani C, Baiocchi LG, de Manzoni G. Lymphnode involvement in gastric cancer for different tumor sites and T stage: Italian Research Group for Gastric Cancer (IRGGC) experience. J Gastrointest Surg 2007; 11: 1146-1153
16. Kim MA, Lee HS, Yang HK, Kim WH. Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach. Cancer 2005; 103: 1439-1446
17. Ichikura T, Tomimatsu S, Uefuji K, Kimura M, Uchida T, Morita D, Mochizuki H. Evaluation of the New American Joint Committee on Cancer/ International Union against cancer classification of lymph node metestasis from gastric carcinoma in comparison with the Japanese classification. Cancer 1999; 86: 553-558
18. Lee HK, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg 2001; 88: 1408-1412
19. Roder JD, Bottcher K, Busch R, Wittekind C, Hermanek P, Siewert JR. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 1998; 82: 621-631
20. Berger AC, Sigurdson ER, LeVoyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ, Haller DG. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 2005; 23: 8706-8712
21. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS, Kim C. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 2007; 14: 1712-1717
22. Pawlik TM, Gleisner AL, Cameron JL, Winter JM, Assumpcao L, Lillemoe KD, Wolfgang C, Hruban RH, Schulick RD, Yeo CJ, Choti MA. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery 2007; 141: 610-618
23. van der Wall BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002; 28: 481-489
24. Bando E, Yonemura Y, Taniguchi K, Fushida S, Fujimura T, Miwa K. Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 2002; 9: 775-784
25. Liu C, Lu P, Lu Y, Xu H, Wang S, Chen J. Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer 2007; 7: 200
26. Wu CW, Hsieh MC, Lo SS, Tsay SH, Lui WY, Veng FK. Relation of number of positive lymph nodes to the prognosis of patients with primary gastric adenocarcinoma. Gut 1996; 38: 525-527
27. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, Roviello F, de Manzon! G, Minicozzi A, Natalini G, De Santis F, Baiocchi L, Coniglio A, Nitti D. The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007; 245: 543-552
28. Nitti D, Marchet A, Olivieri M, Ambrosi A, Mencarelli R, Belluco C, Lise M. Ratio between metastatic and examined lymp nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003; 10: 1077-1085
29. Takagane A, Terashima M, Abe K, Araya M, Irinoda T, Yonezawa H, Nakaya T, Inaba T, Oyama K, Fujiwara H, Saito K. Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer. Gastric Cancer 1999; 2: 122-128
30. Hyung WJ, Noh SH, Yoo, CH, Huh JH, Shin DW, Lah KH, Lee JH, Choi SH, Min JS. Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 2002; 26: 323-329
31. Kim DY, Joo JK, Ryu SY, Park YK, Kim YJ, Kim SK. Clinicopathological characteristics and prognosis of carcinoma of the gastric cardia. Dig Surg 2006; 23: 313-318
32. Volpe CM, Driscoll DL, Miloro SM, Douglass HO Jr. Survival benefit of extended D2 resection for proximal gastric cancer. J Surg Oncol 1997; 64: 231-236
33. Barbour AP, Rizk NP, Gonen M, Tang L, Bains MS, Rusch VW, Colt DG, Brennan MF. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome. Ann Surg Oncol 2007; 14: 306-316
34. Gee DW, Rattner DW. Management of gastroesophageal tumors. Oncology 2007; 12: 175-185
35. McKee MD, Posner MC. The staging of gastric cancer: nothing novel but perhaps better. Ann Surg Oncol 2003; 10: 1005-1006